Afsaneh Shirani

18PUBLICATIONS
10CO-AUTHORS
Tumour immunologyAutoimmunityGene and molecular therapyPredictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 23, 2026
Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathways.

Afsaneh Shirani, Olaf Stuve

|Nov 21, 2025
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System.

Afsaneh Shirani, Samuel A Goldlust, Olaf Stuve

|Oct 07, 2024
Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy.

Afsaneh Shirani, Nil Saez-Calveras, Jack P Antel

|Apr 03, 2024
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

Afsaneh Shirani, Anne H Cross, Olaf Stuve

|Aug 15, 2023
Disseminated Aspergillosis in a Patient With Neurosarcoidosis: Persistent Contrast Enhancement in CNS Despite Prolonged Antifungal Treatment: A Case Report.

Lakshman Arcot Jayagopal, Afsaneh Shirani, Kelly Cawcutt

|Sep 23, 2022
Anti-Neurofascin Antibodies Associated with White Matter Diseases of the Central Nervous System: A Red Flag or a Red Herring?

Navnika Gupta, Afsaneh Shirani, Lakshman Arcot Jayagopal

Pageof 3

Frequent Collaborators

8 joint publications

Olaf Stuve

2 joint publications

Lakshman Arcot Jayagopal

1 joint publications

Anne H Cross

1 joint publications

Natalia Gonzalez Caldito